Full-Time
Posted on 9/9/2024
Specialized clinic offering colon hydrotherapy services
Mid, Senior
Remote in USA
Candidates from Greater D.C, NJ, or OH would be considered.
Clearway Health is a Los Angeles clinic that specializes in colon hydrotherapy, a process that gently infuses filtered water into the colon to cleanse it of waste and toxins. The clinic serves clients seeking relief from constipation, preparing for colonoscopies, or looking to detoxify. Clearway Health stands out by promoting a holistic approach to health, emphasizing self-love and care in its services. The goal is to provide a supportive environment that helps clients achieve better health and happiness.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Los Angeles, California
Founded
N/A
Help us improve and share your feedback! Did you find this helpful?
Professional Development Budget
Paid Holidays
We are honored that Middlesex Hospital has chosen Clearway Health as their partner and are grateful for their trust and commitment to our partnership and mutual success.
BOSTON - Clearway Health, a specialty pharmacy services company partnering with hospitals and health systems to build and strengthen specialty pharmacy programs, has announced a strategic partnership with Sinai Chicago to expand specialty pharmacy services for patients.
Clearway Health appoints Sheri Zee as chief people officer.
To smooth accessibility to gene therapy, Children's National Hospital recently announced a partnered with Clearway Health, a specialty pharmacy solutions company born out of Boston Medical Center.
Accelerating Payor, Legal and Procurement Pathways Paves the Way for Breakthrough Therapy for Pediatric Patient with Rare Disease at Children's National HospitalBOSTON, Jan. 16, 2024 /PRNewswire/ -- Clearway Health, a specialty pharmacy accelerator partnering with hospitals and health systems, has pioneered a model to support hospitals in enabling access to novel gene therapy treatments. The model was used to execute and accelerate payor, legal and procurement processes for Children's National Hospital in Washington, D.C., to treat their first pediatric patient with ZYNTEGLO®, a one-time, potentially curative breakthrough gene therapy treatment for transfusion-dependent beta-thalassemia, a rare blood disorder requiring regular red blood cell transfusions."Novel gene therapies represent the advancement of emerging therapies addressing the possibility of untethering patients from a lifetime of burdensome, costly, chronic care with a single treatment. While very promising, the full clinical impact of these treatments is not yet clear, driving questions on coverage, cost efficiency and delivery," said Shawn Francis, PharmD, director of specialty pharmacy at Clearway Health.Clearway Health launches innovative model to support health systems in enabling access to breakthrough gene therapy. Post thisBy 2030, 54 approved gene and cell therapies are expected in the FDA pipeline, making it essential for healthcare institutions to adequately prepare to deliver gene therapy.Navigating a potentially multimillion-dollar drug therapy involves a multidisciplinary approach that can be extremely time intensive and costly for health systems, involving an understanding of payor dynamics, prior authorizations, geographic complexities, patient financial access, assessment of proper staff training, legal and risk management, orchestration of stakeholders and determining a procurement pathway. Clearway Health's innovative framework supports health systems in navigating these dynamics, as well as the various intricacies that make it possible to absorb the high costs of a one-time, lump sum payment while protecting the financial integrity of the institution."Many health systems are not set up to coordinate the procurement of a novel gene therapy